- 米国企業
- ABEONA THERAPEUTICS INC.
ABEONA THERAPEUTICS INC.ABEO
時価総額
$1.4億
PER
2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
License and other revenues | 2 | 4 | 2 | 925,000 | 1 | 889,000 | 837,000 | 3 | - | 10 | 3 | 1 |
Royalties | - | - | - | - | - | - | - | - | - | - | - | 0 |
Research and development | 4 | 2 | 884,000 | 333,000 | 5 | 11 | 17 | 39 | 49 | 30 | 34 | 29 |
General and administrative | 4 | - | - | - | 14 | 13 | 11 | 20 | 21 | 24 | 23 | 17 |
Impairment of goodwill | - | - | - | - | - | - | - | - | - | - | 32 | - |
Impairment of licensed technology | - | - | - | - | - | - | - | - | - | - | - | 1 |
Impairment of right-of-use lease assets | - | - | - | - | - | - | - | - | - | - | - | 3 |
Impairment of construction-in-progress | - | - | - | - | - | - | - | - | - | - | - | -2 |
Total expenses | 10 | 9 | 6 | 4 | 20 | 25 | 29 | 61 | 77 | 91 | 93 | 52 |
Loss from operations | -7,876,000 | -4,316,000 | -3,804,000 | -3,131,000 | -18,546,000 | -23,881,000 | -27,836,000 | -58,166,000 | -77,090,000 | -81,420,000 | -89,836,000 | -51 |
Gain on settlement with licensor | - | - | - | - | - | - | - | - | - | - | 7 | - |
PPP loan payable forgiveness income | - | - | - | - | - | - | - | - | - | - | 2 | - |
Interest income | - | - | - | - | - | - | - | - | - | - | - | 0 |
Interest expense | - | - | - | - | - | - | - | - | - | - | 4 | 1 |
Change in fair value of warrant liabilities | - | - | - | - | - | - | - | - | - | - | - | -11 |
Other income | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net loss | -2,532,000 | -10,532,000 | 4 | -26,778,000 | -14,526,000 | -21,873,000 | -27,319,000 | -56,671,000 | -76,282,000 | -84,234,000 | -84,936,000 | -40 |
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 4 |
Net loss attributable to Common Shareholders | -4,306,000 | -12,531,000 | 2 | -29,653,000 | -14,526,000 | - | - | - | - | - | - | -43 |
Basic and diluted loss per common share | - | - | 0.06 | -15.26 | - | - | - | - | - | - | - | -5.53 |
Change in unrealized gains (losses) related to available-for-sale debt securities | - | - | - | - | - | - | - | - | - | -10,000 | 9,000 | -0 |
Foreign currency translation adjustments | - | - | - | - | - | - | - | - | - | - | -26,000 | -0 |
Comprehensive loss | - | - | - | - | - | - | - | - | - | -84,244,000 | -84,953,000 | -44 |